Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value Peer-spectives
Filter by Topic
ASCO’s Value Framework
Commentary
Employers’ Perspective
Letter to our Readers
Oncologist–Patient Communication
Patient Communication
Patient Perspective
Payer’s Perspective
Practice Management
Testimonials
The Patient Perspective
Value in Oncology
Value Propositions
VBCC Perspectives
Is the Promise of Health Information Technology More than a Hope and a Prayer? This Year at HIMSS
By
Craig Deligdish, MD
From the Editor
,
Value Peer-spectives
March 2014, Vol 5, No 2
>At the end of February, I had the opportunity to attend the Healthcare Information and Management Systems Society (HIMSS)14 Annual Conference, which was held in Orlando, FL. Attended by more than 30,000 committed vendors, healthcare administrators, providers, politicians, scientists, and others, the meeting provided a great deal of insight into the health information community’s past accomplishments, the present state of the art, and expectations for the future.
Read Article
Aetna Announced First Patient-Centered Medical Home in Oncology
By
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
February 2014, Vol 5, No 1
This collaborative program is based on evidence-based decision support in cancer care, using personalized medicine and realigning payment structure with the goal of increasing patient treatment coordination, improving quality outcomes, and reducing overall costs of cancer care.
Read Article
M.D. Anderson’s Scientists Collaborate with Pfizer to Enhance Immunotherapy in Oncology
By
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
February 2014, Vol 5, No 1
Researchers at the University of Texas M.D. Anderson Cancer Center have announces a new collaboration with Pfizer to develop immune-based approaches to new therapies for cancer. This new effort is based on M.D. Anderson’s Moon Shots Program that aims to reduce cancer deaths significantly in the future, using the 6 moon shots that target 8 types of difficult-to-treat cancer.
Read Article
ASCO Launches Value in Cancer Care Initiative
By
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
February 2014, Vol 5, No 1
Responding to the relentless economic pressures on patients and oncologists and the ever-escalating costs of cancer care delivery, the American Society of Clinical Oncology (ASCO), in collaboration with the Value in Cancer Care Task Force, is developing a working definition of “value” in oncology, as well as identifying how to incorporate the implications of that approach into clinical decision-making in patient care.
Read Article
NCI Pilot Trial to Assess Value of Genetic Sequencing for Improving Patient Outcomes
By
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
February 2014, Vol 5, No 1
The National Cancer Institute (NCI) has launched a clinical trial to determine whether selecting therapies based on genetic mutations can improve outcomes in patients with metastatic solid tumors.
Read Article
Innovating Cancer Care to Improve Value: Health Care Innovation Awards Round Two
By
Craig Deligdish, MD
From the Editor
,
Value Peer-spectives
February 2014, Vol 5, No 1
The Patient Protection and Affordable Care Act (ACA) has been a major topic in the news of late. In addition to providing better healthcare and allowing the uninsured to obtain affordable insurance coverage, the ACA has provided funding for outcomes research and healthcare innovation.
Read Article
The Cost of End-of-Life Care in Oncology
By
Craig Deligdish, MD
End-of-Life Care
,
From the Editor
,
Policies & Guidelines
,
Value Peer-spectives
November 2013, Vol 4, No 9
The recent Institute of Medicine report “Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis” addressed the important issues of delivering high-quality cancer care, including end-of-life care.
Read Article
Physician-Focused Improvement in Patient Satisfaction at the Cleveland Clinic
By
Rosemary Frei, MSc
Patient Communication
,
Value Peer-spectives
November 2013, Vol 4, No 9
>Phoenix, AZ—The degree of patient satisfaction with healthcare is becoming paramount in the new era of value-based care, according to James Merlino, MD, Chief Experience Officer, and Associate Chief of Staff, Patient Experience Office, Cleveland Clinic Health System (CCHS), OH, who discussed high-value healthcare at the American Medical Group Association 2013 Institute for Quality Leadership conference.
Read Article
Empire Genomics to Launch New CLIA-Approved Tests in 2014 for Myeloma, Prostate Cancer
Value Propositions
,
Value Peer-spectives
November 2013, Vol 4, No 9
Empire Genomics, an emerging molecular diagnostics company focused on cancer diagnostics, has recently received approval from the New York State Department of Health for its diagnostic test facility.
Read Article
Translating Cancer Genetics into Patient Care Focus of New Joint Center for Precision Medicine
Value Propositions
,
Value Peer-spectives
November 2013, Vol 4, No 9
A new collaborative initiative among Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston Children’s Hospital, and the Broad Institute of MIT and Harvard has been established to create treatment pathways based on precision (or personalized) medicine for patients with advanced cancer and to try to accelerate the development of personalized therapies.
Read Article
Page 5 of 16
1
2
3
4
5
6
7
8
9
10
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma